HSBC HOLDINGS PLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 2.3%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$50,727
-61.3%
16,155
+40.5%
0.00%
Q2 2022$131,000
-49.8%
11,500
-59.5%
0.00%
Q1 2022$261,000
+4.0%
28,429
+69.7%
0.00%
Q4 2021$251,000
-64.0%
16,749
-38.1%
0.00%
-100.0%
Q3 2021$698,000
-37.2%
27,067
-36.3%
0.00%0.0%
Q2 2021$1,111,000
+173.6%
42,460
+269.2%
0.00%
Q1 2021$406,000
+2.8%
11,500
-26.3%
0.00%
-100.0%
Q4 2020$395,000
-37.7%
15,610
-6.9%
0.00%0.0%
Q3 2020$634,000
+28.9%
16,766
+45.8%
0.00%0.0%
Q2 2020$492,000
+100.8%
11,500
-11.1%
0.00%0.0%
Q1 2020$245,00012,9390.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders